Skip to main content

Table 1 Description of similar patterns of more than five amino-acids obtained in vaccine antigenic proteins and SARS-CoV-2 proteins

From: In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Vaccine No of similar segment Vaccine protein SARS-CoV-2 protein
Designation Segment Position Designation Segment Position
Poliovirus 2 VP1 protein (Sabin 1) GTAPARIS 188–195 N GTSPARMA 203–211
VP1 protein (Sabin 3) LDPLSE 289–295 S LDPLSE 293–299
Measles 2 Fusion protein QECLRG 359–364 ORF6 QECVRG 21–27
IQVGSRR 433–440 ORF8 IRVGARK 47–54
Streptococcus pneumoniae 2 Capsular polysaccharide biosynthesis protein (serotype19F, 18C, 14, 7, 4, 1) IGFLAGVI 182–190 S LGFIAGLI 1218–1226
Capsular polysaccharide biosynthesis protein (serotype19F, 18C, 14, 5) SSVAFA 33–39 S NSVAYS 703–708
Hib 2 Capsular polysaccharide biosynthesis protein KNINDS 210–215 S KNLNES 1191–1196
FILNKKI 73–79 ORF1a FLLNKEM 3183–3189
BCG 1 Immunogenic protein MPB64 IFMLVT 5–11 E VFLLVT 25–31
Tetanus 1 Toxin protein NILMQY 84–90 S NLLLQY 751–756
Mumps virus 1 Fusion protein DISTEL 448–454 S DISTEI 467–473
Hepatitis B 1 HBs Ag-adr PGTSTTS 111–117 S PGTNTSN 600–606